AI-powered HitRix platform streamlines large-group submissions, multi-market quoting, proposal comparison and placement in one secure environment, thereby reducing time to market.

STUART, Fla., Sept. 30, 2026 /PRNewswire/ — Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company (“Health In Tech” or the “Company”), today announced the launch of HitRix, a new AI-powered platform designed to simplify one of the most complex and manual workflows in the large-group self-funded health insurance market, aiming to increase the efficiency of the process and speed to market, and representing another growth lever for the Company.

The Company also updated its full-year 2026 revenue outlook to approximately $33 million, roughly in line with 2025 revenue, primarily reflecting the timing of several strategic initiatives during 2026. Health In Tech expects HitRix, the Company’s Three-Year Rate Stabilization Program, which is a differentiated solution designed to provide employers with greater predictability in stop-loss pricing over a multi-year period, and expanded carrier capacity, to become more meaningful growth contributors beginning in 2027 and beyond.

Solving a Complex Large-Group Workflow

For brokers serving larger employers, bringing a case to market can require collecting significant volumes of employee census information, claims data, plan documents and other sensitive information; organizing files received in multiple formats; preparing submissions for different carriers and managing general underwriters (“MGUs”); tracking responses; and manually comparing proposals. HitRix is designed to simplify that process.

Through HitRix, brokers can securely upload case information in the formats in which they receive it. HitRix uses AI-powered document intelligence to ingest, extract, organize and structure the information, reducing the need for manual data entry and reformatting.

The platform then enables brokers to manage submissions across multiple carriers and MGUs, track market activity in one environment, organize incoming proposals and compare alternatives more efficiently.

By reducing repetitive administrative work, HitRix is designed to allow brokers to spend more time advising clients and less time managing documents, spreadsheets, emails and multiple insurance portals.

Unlike traditional submission tools focused primarily on document routing or RFP management, HitRix is integrated with Health In Tech’s broader underwriting and marketplace infrastructure, connecting submission, market access, analytics and transaction execution within one environment.

Established Distribution Foundation

HitRix launches across Health In Tech’s existing distribution ecosystem, which included 933 partners across brokers, third party administrators and agencies as of June 30, 2026, representing 19.9% year-over-year growth.

The Company believes this established network provides a foundation for HitRix’s adoption and continued expansion across participating carriers and MGUs. As more transactions move through the platform, Health In Tech also expects to build a growing base of structured market and placement data that can support additional analytics, workflow automation and AI-enabled capabilities.

“The challenge we are solving with HitRix goes far beyond putting an insurance submission online,” said Tim Johnson, Chief Executive Officer of Health In Tech. “Large-group brokers often manage substantial amounts of census data, claims information and plan documents across different formats and systems. HitRix is designed to let AI handle much of that administrative work while giving brokers one environment to organize the case, access multiple markets and compare proposals.” 

“Our goal is to make it dramatically easier for brokers to shop the market while keeping them at the center of the client relationship,” Johnson added. “We believe HitRix represents an important step toward building a more connected and intelligent marketplace for self-funded health insurance.”

2026 Outlook and 2027 Growth Drivers

For full-year 2026, Health In Tech expects revenue of approximately $33 million, roughly in line with 2025 revenue. This revised outlook primarily reflects the timing of HitRix commercialization, the Three-Year Rate Stabilization Program and additional carrier capacity, which affect the timing of new policy effective dates and related revenue recognition.

The Company expects these initiatives to contribute more meaningfully in 2027 and beyond as adoption increases, carrier capacity expands and new business becomes effective.

About Health In Tech 

Health In Tech, Inc. (Nasdaq: HIT) is an AI-enabled InsurTech platform company, which offers a marketplace that aims to improve processes in the health insurance industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, managing general underwriters (“MGUs”) and third-party administrators (“TPAs”). Health In Tech’s platform serves as a marketplace for brokers, TPAs, MGUs and carriers to access self-funded health insurance for employers, providing functions including customized self-funded health plans, bindable stop-loss quotes, AI-enabled underwriting, claims administration and reporting integration.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements relating to Health In Tech, Inc.’s (“Health In Tech,” “HIT,” “we,” “us” or “our”) business strategy, product development and innovation, market opportunities, updated revenue outlook, expected timing and magnitude of contribution from new products, growth prospects, and future operating and financial performance. In some cases, forward-looking statements can be identified by terminology such as “believe,” “may,” “will,” “potentially,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “could,” “would,” “project,” “plan,” “target” or similar expressions that are predictions of or indicate future events or trends and that do not relate solely to historical matters. Forward-looking statements in this press release include, but are not limited to: statements regarding the expected functionality, benefits and adoption of HitRix; expansion of marketplace participation; increased activity and data generated through the platform; the Company’s updated 2026 revenue outlook; expectations regarding the timing and magnitude of revenue contribution from new products including HitRix and the Three-Year Rate Stabilization Program; expectations for 2027 and beyond; the timing of the Company’s carrier transition; and the Company’s expectations regarding analytics, automation, AI-enabled capabilities and broader platform strategy.

These forward-looking statements are based on current expectations and beliefs concerning future developments and their potential effects on Health In Tech and are subject to numerous known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside of Health In Tech’s control, that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These factors include, but are not limited to: our ability to obtain funding for our operations and to enhance our current systems and expand our service offerings; the success, cost and timing of our product development activities; the timing and terms of our carrier relationships, including carrier transitions and onboarding of new carriers; our ability to attract and retain key personnel and qualified employees; our ability to attract new customers and to develop new, and enhance existing, products and services; the impact of competition in our industry and innovation by our competitors; risks related to cybersecurity incidents or other network disruptions; risks related to the use of third-party artificial intelligence; our ability to comply with new or modified laws and regulations applicable to our business, including with respect to the insurance services industry, data privacy requirements and AI; our ability to protect our intellectual property rights and maintain and build our brand; the future trading price of our common stock; and other risks and uncertainties described in the “Risk Factors” section of our most recent Annual Report on Form 10-K and our subsequent Quarterly Reports on Form 10-Q and other filings with the U.S. Securities and Exchange Commission.

Any forward-looking statement made in this press release speaks only as of the date of this press release. New risks and uncertainties may emerge from time to time, and it is not possible for Health In Tech to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this press release. Except as required by applicable law, Health In Tech does not undertake, and expressly disclaims, any obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this press release.

Investor Contact:

Health In Tech Investor Relations
ir@healthintech.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/health-in-tech-launches-hitrix-to-modernize-the-nearly-1-trillion-us-self-funded-health-insurance-market-and-announces-updated-2026-full-year-revenue-guidance-302894826.html

SOURCE Health In Tech Inc.

BETHESDA, Md., Sept. 30, 2026 /PRNewswire/ — AGNC Investment Corp. (Nasdaq: AGNC) (“AGNC” or the “Company”) announced today it will report third quarter 2026 earnings after market close on October 19, 2026. AGNC will hold a stockholder call and audio webcast on October 20, 2026 at 8:30 am ET. Callers who do not plan on asking a question and have internet access are encouraged to utilize the webcast at www.AGNC.com. Those who plan on participating in the Q&A or do not have internet available may access the call by dialing (877) 300-5922 (U.S. domestic) or (412) 902-6621 (international). Please advise the operator you are dialing in for the AGNC Investment Corp. stockholder call.

A slide presentation will accompany the call and will be available in the Investors section of the Company’s website at www.AGNC.com. Select the Q3 2026 Stockholder Presentation link to download the presentation in advance of the stockholder call.

An archived audio of the stockholder call combined with the slide presentation will be available on the AGNC website after the call on October 20, 2026. In addition, there will be a phone recording available one hour after the call on October 20, 2026 through November 3, 2026. Those who are interested in hearing the recording of the presentation can access it by dialing (855) 669-9658 (U.S. domestic) or (412) 317-0088 (international), passcode 5388054.

For further information or questions, please contact Investor Relations at (301) 968-9300 or IR@AGNC.com.  

ABOUT AGNC INVESTMENT CORP.
Founded in 2008, AGNC Investment Corp. (Nasdaq: AGNC) is a leading investor in Agency residential mortgage-backed securities (Agency MBS), which benefit from a guarantee against credit losses by Fannie Mae, Freddie Mac, or Ginnie Mae. We invest on a leveraged basis, financing our Agency MBS assets primarily through repurchase agreements, and utilize dynamic risk management strategies intended to protect the value of our portfolio from interest rate and other market risks.

AGNC has a track record of providing favorable long-term returns for our stockholders through substantial monthly dividend income, with over $16 billion of common stock dividends paid since inception. Our business is a significant source of private capital for the U.S. residential housing market, and our team has extensive experience managing mortgage assets across market cycles. AGNC is a member of many broad market indices, including the S&P MidCap 400, the S&P Composite 1500, the Russell 1000, the Russell 3000, and the Nasdaq Composite. To learn more about The Premier Agency Residential Mortgage REIT, please visit www.AGNC.com, follow us on LinkedIn and X, and sign up for Investor Alerts.

CONTACT: Investor Relations – (301) 968-9300

View original content:https://www.prnewswire.com/news-releases/agnc-investment-corp-announces-date-for-third-quarter-earnings-release-and-stockholder-call-302894640.html

SOURCE AGNC Investment Corp.

News Highlights

Leading portfolio of engineering solutions positions Synopsys to capitalize on the continued expansion of digital and physical AI and the AI-driven transformation of engineering.Updates long-term growth targets to reflect accelerating revenue and expanding non-GAAP operating margins. Company expects fiscal year 2027 revenue growth of approximately 15% year over year to $11.15 billion at the midpoint of guidance range.After investing in the business, Synopsys expects to return up to 50% of free cash flow to shareholders via share repurchases; with intent to repurchase approximately $1 billion in shares over the coming months, subject to market conditions.

SUNNYVALE, Calif., Sept. 30, 2026 /PRNewswire/ — Synopsys, Inc. (NASDAQ: SNPS) today detailed its long-term growth strategy and sustainable long-term financial model at its 2026 Investor Day in New York. Management outlined how AI is driving demand, transforming engineering, unlocking new business models and accelerating growth across the portfolio. A replay of the presentation will be available on Synopsys’ investor relations website.

Synopsys President and CEO, Sassine Ghazi, said: “AI is creating multiple, reinforcing growth engines for Synopsys. The acceleration of frontier intelligence is fueling an unprecedented demand for compute power while increasing system complexity. Simultaneously, purpose-built silicon is reshaping the IP market, while Physical AI and agentic workflows are driving deeper integration of our trusted tools. Together, these forces are expanding our addressable market, increasing consumption of our technology, and creating new, recurring revenue streams.”

Highlights from executive presentations include:

Silicon IP Business Expands to Serve Growing Demand for Special-purpose Silicon

Synopsys is expanding beyond traditional standards-based IP into application-optimized IP (AOIP), helping customers develop differentiated silicon tailored to specific workloads and system architectures. As AI drives demand for custom silicon across hyperscalers and system companies, Synopsys is leveraging its interface IP leadership, system expertise, and engineering scale to deliver optimized IP subsystems and platforms that accelerate time-to-market while improving performance and efficiency.

This ‘Factory 2′ IP model expands Synopsys’ value capture per design win and increases its participation in the long-term growth of custom silicon and AI infrastructure. Demonstrating early momentum for the new IP business model, the company has secured multiple AOIP customers spanning compute, ASIC, and AI connectivity architectures. This includes an IP agreement with Amazon, which was announced today.

Powering the Next Frontier of AI-Driven Design

Ghazi today also explained the company’s strategy to create and capture value in the delivery of AI-powered engineering solutions and announced a groundbreaking partnership with OpenAI to collaborate as preferred partners to develop and deliver GPT-Synopsys, a specialized model for chip design that brings together OpenAI’s frontier AI with Synopsys’ trusted EDA tools and chip design expertise.

Synopsys is advancing the next frontier of AI-driven design and simulation with a strategy that enables customers to adopt its agentic AI portfolio in the way that best fits their engineering environment. Customers can deploy the full Synopsys Autopilot platform, integrate Synopsys agents into their own AI platforms, or leverage frontier AI models optimized for specialized engineering workflows. Across all approaches, Synopsys provides the trusted engineering context, domain-specific agents, and ground-truth execution engines that power the development of the world’s most advanced products. This flexible model expands Synopsys’ opportunity to participate across the emerging AI engineering ecosystem while creating multiple avenues to monetize AI-driven engineering through a combination of subscription and consumption-based models across tools, agents and platform.

Synopsys Fiscal 2027 and Long-term Financial Outlook

Synopsys provided financial guidance for fiscal year 2027 and a comprehensive multi-year financial framework through fiscal year 2030. The company also announced its intent to repurchase approximately $1 billion of Synopsys shares over the coming months, subject to market conditions, underscoring confidence in its long-term cash generation.

Shelagh Glaser, Synopsys CFO, said, “Our updated financial framework reflects confidence in both our growth trajectory and our ability to scale efficiently while helping customers re-engineer their engineering to accelerate AI-powered products. We remain focused on disciplined execution, converting growth into expanding margins and strong free cash flow, while continuing to invest in innovation and deliver sustainable long-term value for our shareholders.”

The company’s updated long-term targets and fiscal year 2027 outlook are provided below:

Presentations and the webcast replay from today’s Synopsys 2026 Investor Day are available at: https://investor.synopsys.com/.

Forward Looking Statements

Certain statements contained herein and in our investor conference call contain forward-looking statements within the meaning of the federal securities laws, including, but not limited to, statements concerning our anticipated financial performance, guidance, long-term financial objectives and projections; anticipated synergies and other benefits; capital allocation plans, including planned share repurchases; revenue growth objectives and the expected timing and pace of realization; operating margin expansion objectives; customer demand, market opportunities and industry trends, including the anticipated impact of artificial intelligence; products, services, technologies, business offerings and models, strategies, and anticipated product performance and customer benefits; partnerships and customer agreements; and our operating structure and growth strategy. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions or the negatives of these words or other comparable terminology to convey uncertainty of future events or outcomes. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties.

Many risks, uncertainties and other factors that could cause Synopsys’ actual future events to differ materially from any future results, time frames, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to: (i) macroeconomic conditions and geopolitical uncertainty in the global economy; (ii) uncertainty in the growth of the semiconductor and electronics industries; (iii) the highly competitive industry in which we operate; (iv) actions by the U.S. or foreign governments, such as the imposition of additional export restrictions or tariffs; (v) consolidation among our customers and our dependence on a relatively small number of large customers; (vi) risks and compliance obligations relating to the global nature of our operations; (vii) failure to realize the benefits expected from the transactions we complete, including the acquisition of ANSYS, Inc. (“Ansys”), or unexpected difficulties or expenditures arising therefrom; (viii) risks related to inaccuracies in, or failures to achieve, our operational and business metrics or forecasts of growth; and (ix) other risks and uncertainties described in our filings with the SEC. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements.

Additional information on potential risks, uncertainties and other factors that could affect Synopsys’ results is included in filings we make with the SEC from time to time, including in the sections entitled “Risk Factors” in our latest Annual Report on Form 10-K and in our latest Quarterly Report on Form 10-Q. The financial information contained in this press release should be read in conjunction with the consolidated financial statements and notes thereto included in Synopsys’ most recent reports on Forms 10-K and 10-Q, each as may be amended from time to time. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond Synopsys’ control, and are not guarantees of future results. Readers are cautioned not to put undue reliance on forward-looking statements, and Synopsys gives no assurances that it will achieve its expectations.

GAAP to Non-GAAP Reconciliations

This press release contains certain forward-looking financial measures that are not in accordance with the U.S. generally accepted accounting principles (“GAAP”). It also includes future estimates for non-GAAP operating margin, non-GAAP tax rate, non-GAAP interest and other income (expense), net, non-GAAP expenses, non-GAAP earnings per diluted share (“EPS”), non-GAAP EPS compound annual growth rate (“CAGR”), free cash flow (“FCF”) and FCF CAGR.

FCF is calculated as cash provided from operating activities less capital expendituresFCF CAGR is calculated as the average annual growth rate of FCF over a period of timeNon-GAAP EPS is calculated as GAAP net income excluding amortization of acquired intangible assets, stock-based compensation, restructuring charges, acquisition/divestiture-related items, loss on sale of strategic investments, and legal matters, adjusted for the difference between GAAP and non-GAAP tax rates, divided by fully diluted outstanding sharesNon-GAAP EPS CAGR is calculated as the average annual growth rate of non-GAAP EPS over a period of timeNon-GAAP expenses are calculated as GAAP expenses, excluding amortization of acquired intangible assets, stock-based compensation, restructuring charges, and acquisition/divestiture-related itemsNon-GAAP operating margin is non-GAAP operating income for a period divided by revenue for the same periodNon-GAAP tax rate is set at a three-year normalized tax rate of 18.0%. In projecting this rate, we evaluated our historical and projected mix of U.S. and international profit before tax, excluding the impact of stock-based compensation, the amortization of purchased intangibles and other GAAP only adjustments.Non-GAAP interest and other income (expense), net is calculated as GAAP interest and other income (expense), net adjusted for the change in fair value of our non-qualified deferred compensation plan

Synopsys continues to provide all information required in accordance with GAAP but acknowledges evaluating its ongoing operating results may not be as useful if an investor is limited to reviewing only GAAP financial measures. Accordingly, Synopsys presents non-GAAP financial measures in reporting its financial results to provide investors with an additional tool to evaluate Synopsys’ operating results in a manner that focuses on what Synopsys believes to be its core business operations and what Synopsys uses to evaluate its business operations and for internal budgeting and resource allocation purposes. These non-GAAP financial measures may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP measures are not based on any comprehensive set of accounting rules or principles, and management exercises judgment in determining which items should be excluded in the calculation of non-GAAP measures. The presentation of non-GAAP financial information is not meant to be considered in isolation from, as superior to or as a substitute for the directly comparable financial measures prepared in accordance with GAAP. These non-GAAP financial measures are meant to supplement, and be viewed in conjunction with, the corresponding GAAP financial measures.

Certain non-GAAP financial measures used by management, as well as the reconciliation of non-GAAP financial measures to their most closely applicable GAAP financial measures, is contained in this press release and in our investor conference call presentation available in the investor relations portion of Synopsys’ corporate website at www.synopsys.com. Synopsys is unable to provide a full reconciliation of non-GAAP tax rate for FY 2027E; non-GAAP interest and other income (expense), net for FY 2027E; non-GAAP operating margin for FY 2028E-FY 2030E; non-GAAP EPS for FY 2028E-FY 2030E; non-GAAP EPS CAGR for FY 2026E-FY 2030E; FCF for FY 2028E-FY 2030E; and FCF CAGR for FY 2026E-FY 2030E projections, targets and guidance measures to the corresponding GAAP financial measures on a forward-looking basis because Synopsys believes that it would not be possible for it to have the information necessary to quantitatively reconcile such measures with sufficient precision without unreasonable efforts due to, among other things, the potential variability and limited predictability of the excluded adjustment items necessary for a full reconciliation such as certain acquisition/divestiture related items, tax deduction variability, changes in the fair value of non-qualified deferred compensation plan, and gains (losses) on the sale of strategic investments. For the same reasons, Synopsys is unable to address the probable significance of the unavailable information. Synopsys is presenting forward looking non-GAAP financial measures for illustrative purposes and may not report on this basis going forward.

Effectiveness of Information

The information provided herein is as of September 30, 2026. Although this press release is expected to remain available on Synopsys’ website through the time Synopsys announces its results for the fourth quarter and fiscal year 2026, its continued availability through such time does not mean that Synopsys is reaffirming or confirming its continued validity. Synopsys undertakes no duty, and does not intend, to update any forward-looking statement, whether as a result of new information, future events or otherwise, unless required by law.

About Synopsys

Synopsys, Inc. (Nasdaq: SNPS) is the leader in engineering solutions from silicon to systems, enabling customers to rapidly innovate AI-powered products. We deliver industry-leading silicon design, IP, simulation and analysis solutions, and design services. We partner closely with our customers across a wide range of industries to maximize their R&D capability and productivity, powering innovation today that ignites the ingenuity of tomorrow. Learn more at www.synopsys.com.

© 2026 Synopsys, Inc. All rights reserved. Synopsys, Ansys, the Synopsys and Ansys logos, and other Synopsys trademarks are available at https://www.synopsys.com/company/legal/trademarks-brands.html. Other company or product names may be trademarks of their respective owners.

Contacts

Investors
Tushar Jain
synopsys-ir@synopsys.com

Media
Cara Walker 
cara@synopsys.com
corp-pr@synopsys.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/synopsys-details-growth-strategy-and-long-term-financial-model-at-2026-investor-day-302894684.html

SOURCE Synopsys, Inc.